Animal evidence is much larger and has been the basis for almost all of the published mechanism work
Estudios recientes han indicado que la administracin de GLP-1 exgeno inhibe la ingesta de alimentos al activar el receptor GLP-1 en el cerebro, llevando a una prdida de peso significativa tanto en animales como en humanos [(Drucker, 2024)]
It is important to discuss any possible side effects with your healthcare provider before undergoing treatment
Our work spans from fundamental mechanistic studies to the development of scalable processes for industrial applications
In the face of this Wild West climate, where compounded drugs may vary in their source, formulation, potency, and purity, The Obesity Society, the Obesity Medical Association, and the Obesity Action Coalition published a joint statement that advised against the use of compounded GLP-1 agonists, citing safety concerns and lack of regulatory oversight
Current trials also exclude people with diabetes, recent heart problems, and eating disorders, which may indicate future contraindications once approved
